Natixis Advisors, L.P. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Natixis Advisors, L.P.

  • $51.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$83.14 - $145.99 $1.1 Million - $1.93 Million
13,251 New
13,251 $1.93 Million
Q1 2022

May 12, 2022
SELL
$110.08 - $142.92 $1.28 Million - $1.66 Million
-11,586 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$99.73 - $148.48 $1.16 Million - $1.72 Million
11,586 New
11,586 $1.6 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email